Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,560 | 168 | 99.6% |
| Education | $11.56 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $735.00 | 60 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $684.90 | 39 | $0 (2024) |
| GENZYME CORPORATION | $261.43 | 16 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $138.31 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $111.50 | 7 | $0 (2024) |
| Philips North America LLC | $61.34 | 3 | $0 (2024) |
| Avadel CNS Pharmaceuticals, LLC | $48.58 | 3 | $0 (2024) |
| Baxter Healthcare | $46.92 | 2 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $46.42 | 3 | $0 (2024) |
| United Therapeutics Corporation | $45.38 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,165 | 75 | AstraZeneca Pharmaceuticals LP ($405.54) |
| 2023 | $734.45 | 45 | GlaxoSmithKline, LLC. ($203.27) |
| 2022 | $257.40 | 18 | GlaxoSmithKline, LLC. ($181.68) |
| 2021 | $47.00 | 3 | GlaxoSmithKline, LLC. ($28.61) |
| 2020 | $53.29 | 4 | Resmed Corp ($17.34) |
| 2019 | $148.73 | 12 | GlaxoSmithKline, LLC. ($52.21) |
| 2018 | $81.20 | 6 | AstraZeneca Pharmaceuticals LP ($28.09) |
| 2017 | $84.98 | 6 | AstraZeneca Pharmaceuticals LP ($56.53) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $1.31 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: Immunology | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Respiratory | ||||||
| 10/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: Immunology | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/25/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $5.86 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,215 | 1,699 | $480,715 | $171,345 |
| 2022 | 13 | 1,320 | 1,792 | $495,630 | $175,111 |
| 2021 | 13 | 1,130 | 1,630 | $472,765 | $168,355 |
| 2020 | 17 | 1,203 | 1,841 | $456,464 | $167,316 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 216 | 359 | $87,403 | $36,331 | 41.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 240 | 342 | $97,128 | $35,593 | 36.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 63 | 161 | $95,956 | $29,172 | 30.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 185 | 190 | $81,700 | $27,695 | 33.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 234 | 358 | $58,415 | $24,037 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 108 | $21,600 | $7,397 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $11,680 | $4,183 | 35.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $5,238 | $1,998 | 38.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 39 | 39 | $7,215 | $1,908 | 26.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 30 | 30 | $5,400 | $1,345 | 24.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 22 | 22 | $4,400 | $691.40 | 15.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 22 | 22 | $2,420 | $587.00 | 24.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 18 | 18 | $2,160 | $408.00 | 18.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 67 | 196 | $116,816 | $36,424 | 31.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 259 | 411 | $90,831 | $35,573 | 39.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 191 | 195 | $83,850 | $31,732 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 191 | 272 | $77,248 | $28,011 | 36.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 269 | 367 | $56,885 | $22,106 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 87 | $17,400 | $6,378 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $17,705 | $6,227 | 35.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 61 | 61 | $11,285 | $3,243 | 28.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 28 | 28 | $5,040 | $1,346 | 26.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 37 | 37 | $7,400 | $1,298 | 17.5% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 32 | 32 | $4,640 | $1,252 | 27.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 31 | 31 | $3,410 | $910.06 | 26.7% |
About Dr. Brian Jaffe, MD
Dr. Brian Jaffe, MD is a Internal Medicine healthcare provider based in Marlton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1346401023.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Jaffe, MD has received a total of $2,572 in payments from pharmaceutical and medical device companies, with $1,165 received in 2024. These payments were reported across 169 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,560).
As a Medicare-enrolled provider, Jaffe has provided services to 4,868 Medicare beneficiaries, totaling 6,962 services with total Medicare billing of $682,126. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location Marlton, NJ
- Active Since 06/24/2008
- Last Updated 05/27/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346401023
Products in Payments
- TRELEGY ELLIPTA (Drug) $443.93
- DUPIXENT (Biological) $370.19
- NUCALA (Biological) $226.32
- AIRSUPRA (Drug) $206.16
- TEZSPIRE (Biological) $182.30
- FASENRA (Biological) $166.05
- OFEV (Drug) $83.27
- (AK6) Vest Therapy (Device) $61.34
- BEVESPI AEROSPHERE (Drug) $58.31
- LUMRYZ (Drug) $48.58
- Hillrom - Life 2000 Ventilation System (Device) $46.92
- ARALAST (Biological) $46.42
- TYVASO (Drug) $45.38
- WAKIX (Drug) $45.14
- LONHALA MAGNAIR (Drug) $40.77
- BREZTRI (Drug) $39.12
- SYMBICORT (Drug) $38.33
- ANORO (Drug) $37.67
- (8874) inCourage (Device) $33.93
- OPSUMIT (Drug) $31.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Marlton
Dr. Beckie Michael, Do, DO
Internal Medicine — Payments: $42,387
Dr. Minhaz Karim, Md, MD
Internal Medicine — Payments: $5,317
Joseph Moran, D.o, D.O
Internal Medicine — Payments: $3,800
Angel Rodis, Md, MD
Internal Medicine — Payments: $2,608
Dr. Michael Kleinman, D.o, D.O
Internal Medicine — Payments: $2,510
Stuart Gould, M.d, M.D
Internal Medicine — Payments: $2,419